Screener
Zevra Therapeutics, Inc. ZVRA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Income tax expense | (4,042) | (2,199) | (10,957) | (3,381) |
| Net income | $8,752 | $74,707 | $46,642 | $71,608 |
| Net income per share of common stock: | ||||
| Basic | $0.14 | $1.24 | $0.76 | $1.20 |
| Diluted | $0.14 | $1.21 | $0.74 | $1.16 |
| Weighted-average shares of common stock outstanding: | ||||
| Basic | 59,155,970 | 54,780,938 | 58,783,034 | 54,440,100 |
| Diluted | 61,336,617 | 56,324,903 | 60,785,625 | 56,062,443 |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s shares (diluted)?
- Zevra Therapeutics, Inc. (ZVRA) reported shares (diluted) of 61.3M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Zevra Therapeutics, Inc.'s shares (diluted) increased by 8.9% year-over-year, from 56.3M to 61.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Zevra Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude